TY  - JOUR 
AU  - Preciado Pérez, Silvia
AU  - Sirerol-Piquer, María Salomé
AU  - Muntion Olave,  Sandra
AU  - Osugui, Lika
AU  - Martí Chillón, Gerardo Javier
AU  - Navarro Bailón, Almudena
AU  - Sepúlveda, Pilar
AU  - Sánchez Guijo Martín, Fermín
PY  - 2021
UR  - http://hdl.handle.net/10366/161394
AB  - [EN] Background: Poor graft function or graft failure after allogeneic stem cell transplantation is an unmet medical need, in which mesenchymal stromal cells (MSC) constitute an attractive potential therapeutic approach. Hypoxia-inducible factor-1α...
LA  - eng
PB  - BioMed Central Ltd, part of Springer Nature
KW  - Engraftment
KW  - HIF-1α
KW  - Stem cell transplantation
KW  - Mesenchymal stromal cells
KW  - Hematopoietic stem cells
KW  - Graft failure
KW  - Poor graft function
KW  - Hematopoietic Stem Cell Transplantation
KW  - Mesenchymal Stromal Cells
KW  - Mesenchymal Stem Cell Transplantation
KW  - Hematopoietic Stem Cells
TI  - Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo
DO  - 10.1186/s13287-021-02669-z
T2  - Stem Cell Research & Therapy
VL  - 12
M2  - 601
ER  -